PDX Portal

Model Details

Patient Information for Model: HCI-003

Model Contact

Model: HCI-003
Model Contact: Alana Welm
Institution: HCI Breast PDX Program
Email: Alana.Welm@hci.utah.edu

Patient Information

Clinical Timeline

Color Keys:

Positive

Negative

N/A

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: HCI-003

Model Details - Initial Implantation of Patient Tissue

Biomarkers & Mutations

Model Details - Acceptable Conditions for Passaging

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

Histology Information for Model: HCI-003

There are no histology images for this model.

Metastasis Information for Model: HCI-003

Patient

PDX

Abdomen

Adrenal gland

Bone

Bones

Brain

CTC

Chest

Chest wall

Contralateral Breast

Dura

Fallopian Tubes

Head

Kidney

Liver

Lung

Lymph node

Lymph nodes

Neck

Ovary

Pancreas

Pericardium

Peritoneal cavity

Peritoneum

Pleura

Pleural effusion

Shoulder

Skin

Spine

Spleen

Thoracic Spine

Thymus

Patient Treatment Information for Model: HCI-003

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response
11	Radiation Therapy	Adjuvant	52.08	52.16	29 days
12	Unspecified Adjuvant Chemotherapy	Adjuvant	52.25	52.33	29 days
13	Paclitaxel	Adjuvant	52.33	52.41	29 days
14	Tamoxifen	Adjuvant	52.58	53.33	274 days	Stable Disease
16	Anastrazole	Adjuvant	53.33	53.41	29 days
18	Gemcitabine/Carboplatin	Adjuvant	54.5	54.67	62 days